Maitreya Medicare Ltd

AI

Maitreya Medicare Ltd

₹ 113 -4.77%
24 Aug - close price
About

Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]

Key Points

Business Overview:[1]
MML is a Surat-based multi-super speciality hospital with a 125-bed capacity and a 50-bed capacity in its subsidiary, Tulip Health Check. Its facility offers a wide range of integrated healthcare services, spanning primary, secondary, and tertiary care. These
include Gastroenterology, Nephrology, General & Laparoscopic Surgery, Urology, Oncology, Oncosurgery, Gynecology and High-Risk Obstetrics, Emergency & Trauma, Cardiology, Orthopedic & Joint Replacement Surgery, Cardiothoracic and Vascular Surgery, Neurology, Critical Care Medicine, Neurosurgery, Spine Surgery, Gastrointestinal Surgery, and Cardiothoracic Surgery, Orthopedic Surgery (Including Joint Replacements and Arthroscopic Surgeries), Hepatocellular Biliary Surgery, etc.

  • Market Cap 76.5 Cr.
  • Current Price 113
  • High / Low 293 / 108
  • Stock P/E
  • Book Value 42.8
  • Dividend Yield 0.00 %
  • ROCE -2.18 %
  • ROE -8.86 %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 2.63 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -4.32% over past five years.
  • Company has a low return on equity of 3.28% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
24.79 23.01 24.36 22.30 23.70 21.15
20.23 21.85 21.18 20.60 22.66 22.64
Operating Profit 4.56 1.16 3.18 1.70 1.04 -1.49
OPM % 18.39% 5.04% 13.05% 7.62% 4.39% -7.04%
0.05 0.22 0.19 0.38 0.23 0.76
Interest 0.39 0.46 0.45 0.35 0.43 1.06
Depreciation 0.64 0.64 0.66 0.84 0.79 0.73
Profit before tax 3.58 0.28 2.26 0.89 0.05 -2.52
Tax % 28.49% 67.86% 26.11% 83.15% 160.00% -3.97%
2.56 0.09 1.67 0.15 -0.04 -2.43
EPS in Rs 5.16 0.13 2.46 0.22 -0.06 -3.59
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
55.93 49.35 39.28 46.08 44.98 44.85
48.68 45.98 32.02 40.08 40.10 45.31
Operating Profit 7.25 3.37 7.26 6.00 4.88 -0.46
OPM % 12.96% 6.83% 18.48% 13.02% 10.85% -1.03%
0.43 0.33 0.53 0.30 0.57 0.99
Interest 0.82 0.78 0.57 0.84 0.80 1.48
Depreciation 1.09 1.32 1.29 1.27 1.44 1.52
Profit before tax 5.77 1.60 5.93 4.19 3.21 -2.47
Tax % 26.52% 28.75% 28.16% 29.12% 41.74% 0.00%
4.24 1.14 4.25 2.97 1.87 -2.47
EPS in Rs 4,240.00 1,140.00 8.57 4.38 2.76 -3.65
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: -4%
3 Years: 5%
TTM: 0%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -234%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -55%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 3%
Last Year: -9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.01 0.01 4.96 6.78 6.78 11.55
Reserves 3.85 4.70 3.81 18.07 19.94 17.48
14.24 12.38 11.59 11.10 10.53 23.12
7.17 7.40 8.55 7.91 10.75 16.29
Total Liabilities 25.27 24.49 28.91 43.86 48.00 68.44
13.84 13.40 11.60 14.32 15.26 40.81
CWIP 0.00 0.00 0.00 0.00 0.00 0.00
Investments 1.07 0.32 0.68 1.47 0.04 0.05
10.36 10.77 16.63 28.07 32.70 27.58
Total Assets 25.27 24.49 28.91 43.86 48.00 68.44

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
4.45 0.08 2.59 -2.50 5.06 8.45
-5.07 -0.02 0.36 -5.44 -7.37 -26.74
2.16 -1.86 -1.59 12.21 3.67 19.04
Net Cash Flow 1.55 -1.80 1.36 4.27 1.36 0.75
Free Cash Flow -1.17 -0.82 3.16 -4.11 2.68 -18.63
CFO/OP 77% 54% 40% -12% 134% -1,863%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 31.91 43.42 90.41 108.52 121.40 89.68
Inventory Days 68.78 40.82 69.86 40.26 36.56 32.07
Days Payable 258.06 221.84 319.59 207.25 199.54 153.10
Cash Conversion Cycle -157.37 -137.61 -159.32 -58.47 -41.58 -31.35
Working Capital Days -4.11 3.11 43.12 73.43 73.68 -9.93
ROCE % 12.33% 32.85% 17.30% 10.77% -2.18%

Insights

In beta
Mar 2019 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Total Bed Capacity
beds

Log in to view insights

Please log in to see hidden values.

Login
Number of Hospitals
hospitals
Number of Specialties
specialties
ARPOB (Average Revenue Per Occupied Bed)
INR
Bed Occupancy Rate
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
73.11% 73.11% 73.11% 73.00% 73.11%
2.53% 0.41% 0.01% 0.00% 0.00%
1.35% 0.00% 0.00% 0.00% 0.00%
23.02% 26.48% 26.88% 27.00% 26.89%
No. of Shareholders 474907986978976

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents